Antagonists have a greater selectivity for muscarinic receptor subtypes in intact cerebellar granule cells than in membranes

Brain Research

Volumn 713, Issue 1-2, 1996, Pages 29-35

  Saunders, Paul A ^a   Hough, Christopher J ^a   Chuang, De Maw ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

intact cerebellar granule cell; intrinsic activity; muscarinic antagonist; selectivity

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ATROPINE; COLCHICINE; CYTOCHALASIN; METHOCTRAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; OTENZEPAD; PARA FLUOROHEXAHYDROSILADIFENIDOL; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CEREBELLUM; CONTROLLED STUDY; GRANULE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

EID: 0029997270     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(95)01458-6     Document Type: Article

References (30)

1. 3 muscarinic receptor subtypes on cerebellar granule cells in primary culture, J. Neurochem., 55 (1990) 334-337.
2. Birdsall, N.M.J., Burgen, A.S.V., Hulme, E.G. and Wells, J.W., The effect of ions on the binding of agonists and antagonists to mus-carinic receptors, The modes of binding of ligands to cardiac muscarinic receptors, Trends Pharmacol. Sci. (1989) 31-34.
3. Brown, J.H. and Goldstein, D., Analysis of cardiac muscarinic receptors recognized by nonquaternary but not quaternary ligands, J. Pharmacol. Exp. Ther., 238 (1986) 580-586.
4. Buckley, N.J., Bonner T.I., Buckley, C.M. and Brann, M.R., Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. J. Pharmacol. Exper. Ther., 35 (1989) 469-476.
5. Burgmisser, E., DeLean, A. and Lefkowitz, R.J., Reciprocal modulation of agonist and antagonist binding muscarinic cholinergic receptor by guanine nucleotide, Proc. Natl. Acad. Sci., 79 (1982) 1732-1736.
6. 50) of an enzymatic reaction, Biochem. Pharmacol., 22 (1973) 3099-3108.
7. Chidiac, P., Hebert, T.E., Valiquette, M., Dennis, M. and Bouvier, M., Inverse agonist activity of beta-adrenergic antagonists, Mol. Pharmacol., 45 (1994) 490-499.
8. Cooper, J.A., Effects of cytochalasin and phalloidin on actin, J. Cell Biol, 105 (1987) 1473-1478.
9. DeLean, A., Hancock, A.A. and Lefkowitz, R.J., Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes, Mol. Pharmacol., 21 (1981) 5-16.
10. Dustin, P., Microtubules, 2nd ed., 1984, Springer-Verlag, New York. pp. 171-232.
11. Fukamauchi, F., Hough, C. and Chuang, D.-M., Expression and agonist-induced down-regulation of mRNAs of m2-and m3-muscarinic acetylcholine receptors in cultured cerebellar granule cells., J. Neurochem., 56 (1991) 716-719.
12. 3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells, Mol. Pharmacol., 44 (1993) 940-949.
13. Gillman, A.G., Rail W.R., Nies, A.S. and Taylor, P., The Pharmacologic Basis of Therapeutics, 8th edn., 1990, Pergamon press, New York, pp. 150-165.
14. Gossuin, A., Maloteaux, J.M., Trouet, A. and Laduron, P., Differentiation between ligand trapping into intact cells and binding of muscarinic receptors, Biochim. Biophys. Acta, 804 (1984) 100-106.
15. Habecker, B.A. and Nathanson, N.M., Regulation of muscarinic acetylcholine receptor mRNA expression by activation of homologous and heterologous receptors, Proc. Natl. Acad. Sci. USA, 89 (1992) 5035-5038.
16. Ho, A.K.S., Duffield, R. and Carrol, T., Subcellular distribution of muscarinic acetylcholine receptors and GTP-binding proteins in brain and heart: effects of phosphorylation and acute and chronic carbachol, Biochem. Arch., 9 (1993) 217-229.
17. Hoover, R.K. and Toews, M.L., Evidence for an agonist-induced ATP-dependent change in muscarinic receptors of intact 1321N1 cells, J. Pharmacol. Exp. Ther., 251 (1989) 63-70.
18. Hulme, B.C., Birdsall, N.M.J. and Buckley, N.J., Muscarinic receptor subtypes, Annu. Rev. Pharmacol. Toxicol., 30 (1990) 633-673.
19. Johnson, L.S., Dunn, K.W., Pytowski, B. and McGraw, T.E., Endosome acidification and receptor trafficking: Bafilomycin A1 slows receptor externalization by a mechanism involving the receptor's internalization motif, Mol. Biol. Cell, 4 (1993) 1251-1266.
20. 2-glandular type muscarinic receptors linked to phosphoinositide turnover, Br. J. Pharmacol., 96 (1989) 271-278.
21. Packard, M.G., Regenold, W., Quirion, R. and White, N.M., Post-training injection of the acetylcholine M, receptor antagonist AF-DX 116 improves memory, Brain Res., 524 (1990) 72-76.
22. Mei, L., Roeske W.R. and Yamamura, H.I., Molecular pharmacology of muscarinic receptor heterogeneity, Life Sci., 45 (1989) 1831-1851.
23. Munson, P.J. and Rodbard, D., LIGAND: A versatile computerized approach for the characterization of ligand binding systems, Anal. Biochem., 107 (1980) 220-239.
24. Rinken A., Subtype-specific changes in ligand binding properties after solublization of muscarinic receptors from baculovirus-infected SF9 insect cell membranes, J. Pharmacol. Exp. Ther., 272 (1995) 8-14.
25. Samama, P., Pei, G., Costa, T., Cotecchia, S. and Lefkowitz, R.J., Negative antagonists promote an inactive conformation of the beta, adrenergic receptor, Mol. Pharmacol., 45 (1994) 390-394.
26. Schutz, W. and Freissmuth, M., Reverse intrinsic activity of antagonists on G protein-coupled receptors, Trends Pharmacol. Sci., 13 (1992) 376-380.
27. 1-adrenergic receptors of DDT1 MF-2 cells, J. Pharmacol. Exp. Ther., 31 (1987) 58-68.
28. 3 receptors in rat tissues and clonal cell lines, Mol. Pharmacol., 40 (1991) 781-789.
29. Xu, J. and Chuang, D.M., Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by agonists, J. Pharmacol. Exp. Ther., 242 (1987) 238-244.
30. Zhu S.J. and Toews M.L., Intact cell binding properties of cells expressing altered beta-adrenergic receptors, J. Pharmacol. Exp. Ther., 45 (1994) 255-261.